ReviewPMID: 11734258
Gonadotropin-releasing-hormone-receptor antagonists.
Lancet, 2001
Lancet review of GnRH receptor antagonists, establishing the clinical foundation for GnRH-based therapies in reproductive medicine
Content reviewed by clinical research staff
Evidence graded using the PeptideScholar A-D system.
Gonadorelin (GnRH)
AFDA Approved
95
Excellent Credibility
FDA ApprovedPrescription Required
Gonadorelin is the synthetic form of gonadotropin-releasing hormone (GnRH), identical in structure to the endogenous decapeptide produced in the hypothalamus. It is FDA-approved for diagnosing hypothalamic-pituitary-gonadal axis function, treating primary hypothalamic amenorrhea, and triggering ovulation in fertility protocols. It acts as a GnRH receptor agonist, stimulating the pituitary to release LH and FSH.
Mechanism of Action
Binds to and activates GnRH receptors (GnRHR) on pituitary gonadotroph cells. Pulsatile administration stimulates gonadotropin release (LH and FSH), which drives gonadal steroidogenesis and gametogenesis. Continuous administration paradoxically suppresses the HPG axis via receptor desensitization. Unlike modified GnRH agonists (leuprolide, triptorelin), native gonadorelin has a short half-life (~2–4 minutes) and is used specifically for pulsatile therapy or diagnostic testing.
Benefits
- FDA-approved for diagnosis of hypothalamic-pituitary-gonadal dysfunction[2]
- Pulsatile gonadorelin therapy restores ovulation in hypothalamic amenorrhea — Lancet reviewed[1]
- Used as ovulation trigger in IVF protocols — included in Cochrane network meta-analyses[3]
- Derivative GnRH antagonists are standard treatment for endometriosis and uterine fibroids[2]
This content is for informational purposes only and does not constitute medical advice.
Gonadorelin (GnRH) - Dosing in Published Research
Reported routes: Subcutaneous injection, Intravenous infusion, Intravenous bolus
Pulsatile therapy: 5–20 μg per pulse every 60–90 minutes via subcutaneous or intravenous pump (Lutrepulse system). Diagnostic use: 100 μg single subcutaneous or intravenous dose, measuring LH response at 15–60 minutes. As a GnRH agonist trigger in IVF: dosage varies by protocol. Requires precise pulsatile delivery to be effective — continuous administration suppresses the axis.
The dosing information above is sourced from published research literature and clinical trials. These are not recommendations. Individual responses vary. Always consult a healthcare provider before considering any peptide-based therapy.
Side Effects
- Well-characterized safety profile from decades of clinical use[1]
- Pulsatile therapy: generally well-tolerated; injection site reactions possible[1]
- Continuous therapy: initial flare effect (temporary hormone surge) followed by suppression[1]
- Continuous therapy may cause menopausal-like symptoms (hot flashes, vaginal dryness)[2]
Discuss Gonadorelin (GnRH) with a doctor
Gonadorelin (GnRH) is FDA-approved and available by prescription. Licensed telehealth providers can evaluate if it's right for you.
Start Visit at Henry MedsGet evaluated by a board-certified clinician via Henry Meds. same-week telehealth visits.
FDA approvedBoard-certified doctorsPrescription if appropriate
PeptideScholar may receive compensation from provider referrals. This does not influence our editorial content.
Approved Treatment Routing
Gonadorelin (GnRH) in PeptideScholar's approved-treatment dataset
Gonadorelin (GnRH) is currently modeled on this site as an approved treatment path for: Diagnosis of HPG axis function; primary hypothalamic amenorrhea (pulsatile therapy). Brand names in the current dataset: Factrel, Lutrepulse, HRF.
Validation note: This block reflects the site's current structured treatment data and internal routing logic. It is not a substitute for checking current prescribing, labeling, payer, or local regulatory details.
Research & Evidence
ReviewPMID: 39159261
Medical management of endometriosis.
Curr Opin Obstet Gynecol, 2024
Review confirming GnRH agonists/antagonists as first-line medical therapy for endometriosis
ReviewPMID: 39547644
Triggering oocyte maturation in IVF treatment in healthy responders: a systematic review and network meta-analysis.
Fertil Steril, 2025
Network meta-analysis including GnRH agonist triggers in IVF, confirming efficacy for oocyte maturation
References
- 1.Gonadotropin-releasing-hormone-receptor antagonists.. Lancet, 2001. "Lancet review of GnRH receptor antagonists, establishing the clinical foundation for GnRH-based therapies in reproductive medicine" [PMID: 11734258]
- 2.Medical management of endometriosis.. Curr Opin Obstet Gynecol, 2024. "Review confirming GnRH agonists/antagonists as first-line medical therapy for endometriosis" [PMID: 39159261]
- 3.Triggering oocyte maturation in IVF treatment in healthy responders: a systematic review and network meta-analysis.. Fertil Steril, 2025. "Network meta-analysis including GnRH agonist triggers in IVF, confirming efficacy for oocyte maturation" [PMID: 39547644]
Recommended Resources
The Peptide Protocols Handbook
Evidence-based reference guide covering mechanisms, research, and clinical applications.
View on AmazonThird-Party Peptide Testing
Independent lab analysis to verify peptide purity and authenticity.
Learn MoreLinks may be affiliate links. See our disclosure.
Wellness Support Products
Tools and supplements that support overall health and vitality.
Smart WiFi Body Scale
Tracks BMI, body fat %, and muscle mass — essential for monitoring GLP-1 progress over time.
$30–60View on Amazon
Digital Kitchen Food Scale
Precise gram-level portion tracking helps maximize weight loss results on GLP-1 therapy.
$10–20View on Amazon
Protein Shaker Bottle Set
Leak-proof mixing bottles for protein shakes — supports consistent protein intake on a smaller appetite.
$12–25View on Amazon
Amazon affiliate links; we may earn a small commission at no extra cost to you. See our disclosure.
Recommended Reading
Books covering peptide science, longevity research, and biohacking frameworks.
The Peptide Protocols
Comprehensive reference for peptide mechanisms, dosing research, and clinical applications.
$20–35View on Amazon
Boundless by Ben Greenfield
Covers peptides, nootropics, hormones, and longevity strategies in an optimization framework.
$25–40View on Amazon
Lifespan by David Sinclair
Evidence-based deep-dive into aging science, directly relevant to longevity peptide research.
$15–28View on Amazon
The Longevity Paradox
Gut-centric aging research with diet and supplementation protocols for extending healthspan.
$15–28View on Amazon
Amazon affiliate links; we may earn a small commission at no extra cost to you. See our disclosure.
Gonadorelin (GnRH) FAQ
Medical Disclaimer
This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations.
Always consult a qualified healthcare provider before starting, stopping, or modifying any treatment. Do not disregard professional medical advice based on information found on this site.
No claims of therapeutic efficacy are made for substances that are not FDA-approved for the discussed indications. Research citations reflect published findings and do not imply endorsement.